Literature DB >> 30680958

Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin.

Thuy Van Lam van1, Teodora Ivanova1, Kornelia Hardes1, Miriam Ruth Heindl2, Rory E Morty3, Eva Böttcher-Friebertshäuser2, Iris Lindberg4, Manuel E Than5, Sven O Dahms6, Torsten Steinmetzer1.   

Abstract

The activation of viral glycoproteins by the host protease furin is an essential step in the replication of numerous pathogenic viruses. Thus, effective inhibitors of furin could serve as broad-spectrum antiviral drugs. A crystal structure of an inhibitory hexapeptide derivative in complex with furin served as template for the rational design of various types of new cyclic inhibitors. Most of the prepared derivatives are relatively potent furin inhibitors with inhibition constants in the low nanomolar or even sub-nanomolar range. For seven derivatives the crystal structures in complex with furin could be determined. In three complexes, electron density was found for the entire inhibitor. In the other cases the structures could be determined only for the P6/P5-P1 segments, which directly interact with furin. The cyclic derivatives together with two non-cyclic reference compounds were tested as inhibitors of the proteolytic activation and replication of respiratory syncytial virus in cells. Significant antiviral activity was found for both linear reference inhibitors, whereas a negligible efficacy was determined for the cyclic derivatives.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  X-ray crystallography; furin inhibitors; macrocyclization; proprotein convertases; respiratory syncytial virus

Year:  2019        PMID: 30680958     DOI: 10.1002/cmdc.201800807

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  12 in total

1.  Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study.

Authors:  Bhabani Shankar Das; Nabarun Chandra Das; Shasank Sekhar Swain; Suprabhat Mukherjee; Debapriya Bhattacharya
Journal:  Future Virol       Date:  2022-07-04       Impact factor: 3.015

2.  Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin.

Authors:  Monika A Lewandowska-Goch; Anna Kwiatkowska; Teresa Łepek; Kévin Ly; Pauline Navals; Hugo Gagnon; Yves L Dory; Adam Prahl; Robert Day
Journal:  ACS Med Chem Lett       Date:  2021-02-05       Impact factor: 4.345

3.  TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.

Authors:  Dorothea Bestle; Miriam Ruth Heindl; Hannah Limburg; Thuy Van Lam van; Oliver Pilgram; Hong Moulton; David A Stein; Kornelia Hardes; Markus Eickmann; Olga Dolnik; Cornelius Rohde; Hans-Dieter Klenk; Wolfgang Garten; Torsten Steinmetzer; Eva Böttcher-Friebertshäuser
Journal:  Life Sci Alliance       Date:  2020-07-23

4.  Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming.

Authors:  Elisa Barile; Carlo Baggio; Luca Gambini; Sergey A Shiryaev; Alex Y Strongin; Maurizio Pellecchia
Journal:  Molecules       Date:  2020-05-22       Impact factor: 4.411

5.  The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin.

Authors:  Thuy Van Lam van; Miriam Ruth Heindl; Christine Schlutt; Eva Böttcher-Friebertshäuser; Ralf Bartenschlager; Gerhard Klebe; Hans Brandstetter; Sven O Dahms; Torsten Steinmetzer
Journal:  ACS Med Chem Lett       Date:  2021-02-09       Impact factor: 4.345

6.  Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication.

Authors:  Yi Zhang; Liang V Tang
Journal:  J Proteome Res       Date:  2020-12-21       Impact factor: 4.466

Review 7.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

Review 8.  The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases.

Authors:  Gonzalo Izaguirre
Journal:  Viruses       Date:  2019-09-09       Impact factor: 5.048

Review 9.  Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches.

Authors:  Magda Gioia; Chiara Ciaccio; Paolo Calligari; Giovanna De Simone; Diego Sbardella; Grazia Tundo; Giovanni Francesco Fasciglione; Alessandra Di Masi; Donato Di Pierro; Alessio Bocedi; Paolo Ascenzi; Massimo Coletta
Journal:  Biochem Pharmacol       Date:  2020-09-19       Impact factor: 5.858

Review 10.  The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity?

Authors:  Annamaria Vianello; Serena Del Turco; Serena Babboni; Beatrice Silvestrini; Rosetta Ragusa; Chiara Caselli; Luca Melani; Luca Fanucci; Giuseppina Basta
Journal:  Biomedicines       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.